Gri Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.77

-0.18 (-9.23%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +2,125.4% upside

Low Target $26.66

Average Target $39.39

High Target $54.88

Current Price $1.77

Current
$1.77

Target
$39.39

$26.66 $39.39 avg $54.88

Scenario Analysis

Bear Case

$26.66

1,406.2%

Low target

Base Case

$39.39

+2,125.4%

Avg target

Bull Case

$54.88

+3,000.6%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$80.36

-97.8% from high

52-Week Low

$1.36

+30.1% from low

Target vs 52W High

$39.39

-51.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.2%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.8%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.8%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.5%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.6%